Phase I and pharmacological study of sequential intravenous topotecan and oral etoposide
- 1 December 1997
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 76 (11), 1500-1508
- https://doi.org/10.1038/bjc.1997.585
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Clinical Pharmacokinetics of TopotecanClinical Pharmacokinetics, 1996
- Phase I Clinical and Pharmacology Study of Topotecan Given Daily for 5 Consecutive Days to Patients With Advanced Solid Tumors, With Attempt at Dose Intensification Using Recombinant Granulocyte Colony-Stimulating FactorJNCI Journal of the National Cancer Institute, 1993
- Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT-29 cellsEuropean Journal of Cancer, 1992
- Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude miceInternational Journal of Cancer, 1992
- Effects of CPT‐11 in combination with other anti‐cancer agents in cultureInternational Journal of Cancer, 1992
- Topoisomerase-targeting antitumor drugsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1989
- Nonproductive Rearrangement of DNA Topoisomerase I and II Genes: Correlation With Resistance to Topoisomerase InhibitorsJNCI Journal of the National Cancer Institute, 1989
- DNA TOPOISOMERASESAnnual Review of Biochemistry, 1985
- High-Performance Liquid Chromatographic Analysis of the Semisynthetic Epipodophyllotoxins Teniposide and Etoposide Using Electrochemical DetectionJournal of Pharmaceutical Sciences, 1984
- Kinetics of pharmacologic responsePharmacology & Therapeutics, 1982